Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8661685 | International Journal of Cardiology | 2018 | 7 Pages |
Abstract
Among consecutive ACS patients, the increased risk of major bleeding during ticagrelor-based DAPT was limited to HBR patients. In both HBR and non-HBR patients, ticagrelor-based DAPT did not reduce ischemic outcomes following treatment with contemporary DES implantation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paolo Zocca, Marlies M. Kok, Liefke C. van der Heijden, K. Gert van Houwelingen, Marc Hartmann, Frits H.A.F. de Man, Martin G. Stoel, J.(Hans) W. Louwerenburg, Iris L. Knottnerus, Gerard C.M. Linssen, Carine J.M. Doggen, Clemens von Birgelen,